Komori
Mitsui DM Sugar (2109) · FactRevenue Growth but Lower Operating Profit, Ordinary Profit and Net Income

Improvement in Sales, Operating Profit, Ordinary Profit, and Net Profit

First written in FY2016. 4 of 37 entries say "Advanced", first in FY2017-Q1. Latest entry: FY2026.

37entries
11years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2019-Q1 – FY20262016: 320162017: 420172018: 320182019: 420192020: 420202021: 420212022: 420222023: 420232024: 320242025: 220252026: 22026
Same theme, other companies
Declines in operating and net profit despite higher revenue, followed by earnings recoveryA theme 65 companies write about · 32 as a headwind · 5 as a tailwind

The whole theme swung hardest in 2020: 15 of 57 companies on the "Worse" side.

29 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 65 companies compared. The sentences above are computed from all 65.
Full recordFilings, disclosures and news, newest first
  1. FY2026Revenue Growth but Lower Operating Profit, Ordinary Profit and Net IncomeAnnual report

    「Revenue for the fiscal year was ¥180,102 million, up 0.7% from the previous fiscal year, and operating profit was ¥12,909 million, down 6.7%. … Ordinary profit was ¥12,640 million, down 12.7%. … Net profit attributable to owners of the parent was ¥3,961 million, down 37.1%.」

    For the year, revenue increased, while operating profit, ordinary profit and net profit attributable to owners of the parent all decreased.
  2. 2026-05-15OtherRevision of earnings forecasts

    「As a result, net sales for the fiscal year were ¥180,102 million, up 0.7% year on year, while operating income was ¥12,909 million, down 6.7% year on year.」

    Net sales increased while operating income declined. Ordinary income was ¥12,640 million and net income attributable to owners of the parent was ¥3,961 million, both below the previous fiscal year.
  3. FY2026-H1Revenue Growth but Lower Operating Profit, Ordinary Profit and Net IncomeAnnual report

    「As a result, revenue for the six months ended the interim period was ¥90,363 million, up 2.6% year on year, and operating profit was ¥6,324 million, down 2.6%. In non-operating income and expenses, royalty income, primarily from royalties under licences for the development and sales rights to fingolimod “FTY720”, decreased, while sales at the Chinese associate also declined. Ordinary profit was ¥6,455 million, down 7.4%. In addition, interim net profit attributable to owners of the parent was ¥4,731 million, down 13.6%, due to lower subsidy income and higher tax-related expenses, among other factors.」

    For the interim period, revenue increased, while operating profit, ordinary profit and interim net profit attributable to owners of the parent all fell below the same period of the previous year.
  4. FY2025Revenue, operating profit and ordinary profit increased, but net profit decreased due to impairment losses and other factors.Annual report

    「Revenue for the fiscal year was ¥178,785 million, up 4.7% from the previous fiscal year, and operating profit was ¥13,840 million, up 225.6%. … Ordinary profit was ¥14,483 million, up 48.1%. … Net profit attributable to owners of the parent was ¥6,295 million, down 25.5%.」

    Revenue, operating profit and ordinary profit increased, while net profit attributable to owners of the parent decreased due to impairment losses and other factors associated with the end of production at 3 companies.
  5. FY2025-H1Revenue, operating profit and ordinary profit increased, but interim net profit decreased.Annual report

    「As a result, revenue for the six months ended the interim period was ¥88,071 million, up 4.6% year on year, and operating profit was ¥6,496 million, up 421.5%. In non-operating income and expenses, the Company recognised ¥344 million in royalty income, primarily from royalties under licences for the development and sales rights to fingolimod “FTY720”. In addition, improved performance at the Thai associate and increased sales of diluted beverages at a domestic associate resulted in the recognition of ¥111 million in equity-method investment income, compared with an investment loss of ¥121 million in the same period of the previous year. Ordinary profit was therefore ¥6,969 million, up 12.6%, but interim net profit attributable to owners of the parent was ¥5,474 million, down 9.8%, due to an increase in tax-related expenses, reflecting a rebound from the previous period.」

    For the interim period, revenue, operating profit and ordinary profit exceeded the same period of the previous year, while interim net profit attributable to owners of the parent fell below the previous year’s level due to higher tax-related expenses.
  6. FY2024Revenue up, operating profit up, ordinary profit down and net profit upAnnual report

    「Revenue for the fiscal year was ¥170,774 million, up 4.6% from the previous fiscal year, and operating profit was ¥4,251 million, up 286.4%. … Ordinary profit was ¥9,778 million, down 48.7%, while net profit attributable to owners of the parent was ¥8,445 million, up 6.8%.」

    Revenue, operating profit and net profit attributable to owners of the parent increased, while ordinary profit decreased due to lower royalty income and deteriorating performance at the Thai associate.
  7. FY2024-Q3Revenue and operating profit increased, while ordinary profit and net profit increased significantly.Annual report

    「As a result, revenue for the nine months ended the third quarter was ¥129,398 million, up 4.6% year on year, and operating profit was ¥2,430 million, up 95.4%. In non-operating income and expenses, DM Mitsui Sugar Co., Ltd. recognised ¥4,457 million in dividends received from domestic investees and ¥971 million in royalty income under licences for the development and sales rights to fingolimod “FTY720”. In addition, equity-method investment income and losses benefited mainly from improved performance at the Thai associate. Ordinary profit was ¥7,369 million, up 704.5%, and quarterly net profit attributable to owners of the parent was ¥6,502 million, compared with a quarterly net loss attributable to owners of the parent of ¥269 million in the same period of the previous year.」

    For the nine months ended the third quarter, revenue and operating profit increased, while dividends received of ¥4,457 million, royalty income of ¥971 million and improved performance at the Thai associate contributed to significant improvements in ordinary profit and quarterly net profit attributable to owners of the parent.
  8. FY2024-Q2Revenue and operating profit increased, while ordinary profit and net profit increased significantly.Annual report

    「As a result, revenue for the six months ended the second quarter was ¥84,217 million, up 6.7% year on year, and operating profit was ¥1,245 million, up 9.5%. In non-operating income and expenses, DM Mitsui Sugar Co., Ltd., a consolidated subsidiary, recognised ¥4,457 million in dividends received from domestic investees. The Company also recognised ¥604 million in royalty income under licences for the development and sales rights to fingolimod “FTY720”. Although equity-method investment income and losses were affected mainly by deteriorating performance due to lower sales volumes at the Thai associate, ordinary profit was ¥6,187 million, up 336.9%, and quarterly net profit attributable to owners of the parent was ¥6,066 million, up 1,193.2%.」

    In addition to increases in revenue and operating profit, dividends received of ¥4,457 million and other factors resulted in ordinary profit increasing 336.9% year on year and quarterly net profit attributable to owners of the parent increasing 1,193.2%.
  9. FY2024-Q1Revenue increased and operating profit decreased, but ordinary profit and net profit increased significantly due to dividends received and other factors.Annual report

    「As a result, revenue for the three months ended the first quarter was ¥42,358 million, up 8.1% year on year, and operating profit was ¥501 million, down 24.0%. In non-operating income and expenses, the Company recognised ¥275 million in royalty income under licences for the development and sales rights to fingolimod “FTY720”. In addition, DM Mitsui Sugar Co., Ltd., a consolidated subsidiary, recognised ¥4,457 million in dividends received from domestic investees. Although equity-method investment income and losses were affected by deteriorating performance due to lower sales and production volumes at associates in Thailand and China, ordinary profit was ¥5,272 million, up 457.4%, and quarterly net profit attributable to owners of the parent was ¥5,549 million, up 677.1%.」

    Revenue increased while operating profit decreased, but ordinary profit and quarterly net profit attributable to owners of the parent increased significantly due to ¥4,457 million in dividends received from domestic investees and other factors.
  10. FY2023Ordinary profit and net profit recovered due to the lump-sum recognition of royalties following the arbitration award.Annual report

    「As a result, the Company recognised the long-term deposits received together with ¥937 million in royalty income for the fiscal year as non-operating income. Although equity-method investment income and losses were affected by lower sales volumes at an associate subject to strict movement restrictions in China amid the spread of COVID-19 and deteriorating performance at the Thai associate, ordinary profit was ¥19,058 million, up 447.8% from the previous fiscal year.」

    Ordinary profit was ¥19,058 million and net profit attributable to owners of the parent was ¥7,911 million due to the recognition of ¥17,552 million in FTY720 royalties and ¥937 million for the current fiscal year.
  11. FY2023-Q3Net sales increased, but operating and ordinary income declined and profit attributable to owners of the parent was a lossAnnual report

    「As a result, revenue for the nine months ended the third quarter was ¥123,763 million, up 10.2% year on year, and operating profit was ¥1,243 million, down 67.0%. Equity-method investment income and losses were affected by lower sales volumes at an associate subject to strict movement restrictions in China amid the spread of COVID-19, as well as deteriorating performance at the Thai associate. Ordinary profit was ¥916 million, down 74.9%. In addition, the Company recognised impairment losses on fixed assets related to assets at the Honbetsu sugar refinery of Hokkaido Sugar Co., Ltd., a consolidated subsidiary, which became unlikely to recover its investment because the assets had become idle, as well as the reversal of deferred tax assets and other items. Consequently, the quarterly net loss attributable to owners of the parent was ¥269 million, compared with quarterly net profit attributable to owners of the parent of ¥2,900 million in the same quarter of the previous year.」

    Revenue increased due to the business integration and other factors, while operating profit decreased 67.0% and ordinary profit decreased 74.9%, resulting in a quarterly net loss attributable to owners of the parent of ¥269 million, including impairment losses at the Honbetsu sugar refinery.
  12. FY2023-Q2Revenue increased, but operating profit, ordinary profit and net profit all decreased.Annual report

    「As a result, revenue for the six months ended the second quarter was ¥78,961 million, up 9.4% year on year, and operating profit was ¥1,137 million, down 52.5%. Equity-method investment income and losses were affected by lower sales volumes at an associate due to strict movement restrictions imposed in China amid the spread of COVID-19, while the Thai associate benefited from partial improvements in its cost ratio due to increased production. Ordinary profit was ¥1,416 million, down 41.5%. In addition, quarterly net profit attributable to owners of the parent was ¥469 million, down 81.0%, partly due to the reversal of the gain on the recognition of negative goodwill from the previous period’s business integration.」

    For the six months ended the second quarter, revenue increased 9.4% due to the business integration and other factors, while operating profit decreased 52.5%, ordinary profit decreased 41.5% and quarterly net profit attributable to owners of the parent decreased 81.0%.
  13. FY2023-Q1Revenue increased, but operating profit, ordinary profit and net profit all decreased.Annual report

    「As a result, revenue for the three months ended the first quarter was ¥39,194 million, up 3.9% year on year, and operating profit was ¥659 million, down 41.9%.」

    In the first quarter, revenue increased while operating profit decreased. Ordinary profit was ¥945 million, down 35.8% year on year, and quarterly net profit attributable to owners of the parent was ¥714 million, down 77.1%.
  14. FY2022Revenue increased through the business integration, operating profit was largely unchanged and ordinary profit decreased, but net profit increased.Annual report

    「With the addition of newly consolidated entities following the business integration, revenue for the fiscal year was ¥147,880 million, compared with ¥108,887 million in the previous fiscal year, and operating profit was ¥3,630 million, compared with ¥3,631 million. … Ordinary profit was ¥3,479 million, compared with ¥3,788 million. … Net profit attributable to owners of the parent was ¥3,657 million, compared with ¥2,764 million.」

    Revenue increased due to the expansion of the scope of consolidation following the business integration, operating profit was largely unchanged and ordinary profit decreased, while net profit attributable to owners of the parent increased due to gains on the recognition of negative goodwill and other factors.
  15. FY2022-Q3Revenue, operating profit and ordinary profit increased, including the business integration, but net profit decreased due to impairment losses.Annual report

    「Hokkaido Sugar Co., Ltd., a consolidated subsidiary, decided to end production at its Honbetsu sugar refinery in March 2023 and consequently recognised ¥1,071 million in impairment losses on fixed assets, among other factors. Quarterly net profit attributable to owners of the parent was therefore ¥766 million, compared with ¥2,636 million in the same quarter of the previous year.」

    Revenue was ¥112,260 million, operating profit was ¥3,773 million and ordinary profit was ¥3,648 million, including the expansion of the scope of consolidation following the business integration, while quarterly net profit attributable to owners of the parent was ¥766 million due to impairment losses at the Honbetsu sugar refinery and other factors.
  16. FY2022-Q2Revenue, operating profit and ordinary profit increased, including the business integration, but net profit decreased.Annual report

    「As a result, revenue for the six months ended the second quarter was ¥72,198 million, compared with ¥53,314 million in the same period of the previous year, and operating profit was ¥2,393 million, compared with ¥2,151 million. … Ordinary profit was ¥2,420 million, compared with ¥1,727 million. In addition, Hokkaido Sugar Co., Ltd., a consolidated subsidiary, recognised ¥1,055 million in impairment losses on fixed assets following the decision to end production at its Honbetsu sugar refinery in March 2023, among other factors. Consequently, quarterly net profit attributable to owners of the parent was ¥338 million, compared with ¥440 million in the same period of the previous year.」

    Revenue, operating profit and ordinary profit exceeded the same quarter of the previous year, including the expansion of the scope of consolidation following the business integration, while quarterly net profit attributable to owners of the parent decreased due to impairment losses at the Honbetsu sugar refinery and other factors.
  17. FY2022-Q1Revenue, operating profit, ordinary profit and net profit all increased, including newly consolidated entities following the business integration.Annual report

    「As a result, revenue for the three months ended the first quarter was ¥37,721 million, compared with ¥26,528 million in the same quarter of the previous year, and operating profit was ¥1,135 million, compared with ¥1,088 million. … Ordinary profit was ¥1,472 million, compared with ¥991 million, and quarterly net profit attributable to owners of the parent was ¥983 million, compared with ¥405 million.」

    The Company disclosed results for revenue, operating profit, ordinary profit and quarterly net profit attributable to owners of the parent for the first quarter, including newly consolidated entities following the business integration.
  18. FY2021Revenue down, operating profit down and ordinary profit down, but net profit upAnnual report

    「Revenue for the fiscal year was ¥108,887 million, down 4.4% from the previous fiscal year, and operating profit was ¥3,631 million, down 25.1%. … Ordinary profit was ¥3,788 million, down 24.0%, while net profit attributable to owners of the parent was ¥2,764 million, up 14.1%.」

    For the year, revenue, operating profit and ordinary profit decreased, while net profit attributable to owners of the parent increased due to gains on the sale of cross-shareholdings and other factors.
  19. FY2021-Q3Lower revenue, lower operating profit, lower ordinary profit and lower net incomeAnnual report

    「As a result, revenue for the nine months ended the third quarter was ¥82,362 million, down 5.3% year on year, and operating profit was ¥3,562 million, down 28.3%. … Ordinary profit was ¥3,460 million, down 27.9%, and quarterly net profit attributable to owners of the parent was ¥2,636 million, down 4.5%.」

    For the first nine months, revenue, operating income, ordinary income and quarterly net income attributable to owners of the parent all fell below the year-earlier levels.
  20. FY2021-Q2Lower revenue, lower operating profit, lower ordinary profit and lower net incomeAnnual report

    「As a result, revenue for the six months ended the second quarter was ¥53,314 million, down 6.2% year on year, and operating profit was ¥2,151 million, down 30.1%. In non-operating income and expenses, the Company recognised ¥284 million in royalty income under licences for the development and sales rights to fingolimod “FTY720”. Although equity-method investment losses improved from the same period of the previous year, their recognition and other factors resulted in ordinary profit of ¥1,727 million, down 43.5%, and net profit attributable to owners of the parent of ¥440 million, down 73.8%.」

    For the first six months, revenue, operating income, ordinary income and quarterly net income attributable to owners of the parent all fell below the year-earlier levels.
  21. FY2021-Q1Lower revenue, lower operating profit, lower ordinary profit and lower net incomeAnnual report

    「As a result, revenue for the three months ended the first quarter was ¥26,528 million, down 7.9% year on year, and operating profit was ¥1,088 million, down 22.2%. In non-operating income and expenses, the Company recognised ¥164 million in royalty income under licences for the development and sales rights to fingolimod “FTY720”. As arbitration proceedings between the Company’s co-patent holder, Mitsubishi Tanabe Pharma Corporation, and Novartis Pharma AG (hereinafter, “Novartis”) remain ongoing, the Company continued not to recognise as revenue the portion concerning which Novartis has raised doubts regarding the validity of the contract. In addition, equity-method investment losses were recognised, resulting in ordinary profit of ¥991 million, down 49.0% year on year, and net profit attributable to owners of the parent of ¥405 million, down 68.3%.」

    In the first quarter, revenue, operating profit, ordinary profit and quarterly net profit attributable to owners of the parent were all below the same period of the previous year.
  22. FY2020Revenue and operating income increased, but ordinary income and net income declinedAnnual report

    「Revenue for the fiscal year was ¥113,854 million, up 8.1% from the previous fiscal year, and operating profit was ¥4,848 million, up 29.5%. In non-operating income and expenses, the Company recognised ¥1,340 million in royalty income under licences for the development and sales rights to fingolimod “FTY720”. As arbitration proceedings between the Company’s co-patent holder, Mitsubishi Tanabe Pharma Corporation, and Novartis Pharma AG (hereinafter, “Novartis”) remain ongoing, the Company continued not to recognise as revenue the portion concerning which Novartis has raised doubts regarding the validity of the contract. As a result, ordinary profit was ¥4,982 million, down 51.7%. In addition, partly due to the recognition of ¥234 million in environmental remediation expenses as an extraordinary loss in connection with a heavy-oil spill at Hokkaido Sugar Co., Ltd., net profit attributable to owners of the parent was ¥2,422 million, down 64.7%.」

    For the year, revenue and operating profit increased, while ordinary profit and profit attributable to owners of the parent declined significantly due to lower royalty income, equity-method investment losses and environmental remediation expenses.
  23. FY2020-Q3Revenue and operating income increased, but ordinary income and net income declinedAnnual report

    「As a result, revenue for the nine months ended the third quarter was ¥86,961 million, up 10.7% year on year, and operating profit was ¥4,966 million, up 63.9%. Although 中糧糖業遼寧有限公司, in which the Company invested in the previous fourth quarter, continued to perform steadily, ordinary profit was ¥4,800 million, down 41.1%, and net profit attributable to owners of the parent was ¥2,759 million, down 45.2%, due to weak performance at the Thai associate amid soft overseas raw sugar prices and the decision not to recognise certain revenue because arbitration proceedings concerning royalties from “FTY720” remain ongoing.」

    Revenue and operating profit increased, driven by the domestic sugar business and other operations, while ordinary profit and profit attributable to owners of the parent decreased due to weak performance at the Thai associate and the decision not to recognise FTY720 royalty income.
  24. FY2020-Q2Revenue and operating income increased, but ordinary income and net income declinedAnnual report

    「As a result, revenue for the six months ended the second quarter was ¥56,861 million, up 11.4% year on year, operating profit was ¥3,078 million, up 89.9%, ordinary profit was ¥3,054 million, down 38.5%, and net profit attributable to owners of the parent was ¥1,677 million, down 46.6%.」

    For the six months ended the second quarter, revenue and operating profit increased, while ordinary profit and profit attributable to owners of the parent decreased due to the amortisation burden on goodwill from overseas investments, deteriorating performance at the Thai associate, and the decision not to recognise certain royalty income.
  25. FY2020-Q1Revenue and operating income increased, but ordinary income and net income declinedAnnual report

    「As a result, revenue for the first quarter of the current consolidated fiscal period was ¥28,795 million, up 7.9% year on year, and operating income was ¥1,398 million, up 23.3%. In non-operating income and expenses, royalty income declined 63.0% year on year because, in response to ongoing arbitration proceedings between Tanabe Mitsubishi Pharma Corporation, the company's co-owner of the relevant patents, and Novartis Pharma AG (hereinafter, Novartis), the company did not recognize as revenue the portion of royalty income under the licence for the development and marketing rights to fingolimod, “FTY720,” concerning which Novartis had raised questions about the validity of the contract. At the Thai affiliate, selling prices declined amid weak overseas raw sugar prices, while affiliates in Okinawa and Kagoshima were affected by lower yields due to adverse weather. As a result, an equity in loss of affiliates of ¥87 million was recorded, ordinary income was ¥1,945 million, down 35.4%, and net income attributable to owners of the parent was ¥1,276 million, down 33.8%.」

    In the first quarter, revenue and operating profit increased, while ordinary profit and profit attributable to owners of the parent decreased due to lower royalty income and equity-method investment losses.
  26. FY2019For the full year, revenue was flat, while operating income, ordinary income and net income declinedAnnual report

    「As a result, revenue for the current consolidated fiscal year was ¥105,274 million, down 0.0% from the previous consolidated fiscal year, and operating income was ¥3,742 million, down 41.1%. In non-operating income and expenses, as described above, the company did not recognize royalty income as revenue for the portion subject to questions raised in arbitration proceedings between Tanabe Mitsubishi Pharma Corporation, the company's co-owner of the relevant patents, and Novartis. Consequently, ordinary income was ¥10,314 million, down 24.2%, and net income attributable to owners of the parent was ¥6,862 million, down 17.5%.」

    FY2019 full-year revenue was broadly flat, while operating income, ordinary income and net income attributable to owners of the parent declined.
  27. FY2019-Q3Lower revenue, lower operating profit, lower ordinary profit and lower net incomeAnnual report

    「As a result, revenue for the first nine months of the current consolidated fiscal period was ¥78,550 million, down 2.7% year on year, and operating income was ¥3,030 million, down 47.8%. Although royalty income amounted to ¥6,053 million, performance at the Thai affiliate deteriorated amid weak overseas raw sugar prices, and adverse weather affected Okinawa and Kagoshima. Ordinary income was ¥8,146 million, down 28.3%, and net income attributable to owners of the parent was ¥5,031 million, down 30.3%.」

    For the first nine months, revenue, operating income, ordinary income and quarterly net income attributable to owners of the parent all fell below the year-earlier levels.
  28. FY2019-Q2Lower revenue, lower operating profit, lower ordinary profit and lower net incomeAnnual report

    「As a result, revenue for the first six months of the current consolidated fiscal period was ¥51,020 million, down 2.7% year on year, and operating income was ¥1,621 million, down 54.8%. Although royalty income amounted to ¥3,934 million, ordinary income was ¥4,971 million, down 38.6%, due mainly to an equity in loss of affiliates of ¥485 million related primarily to the Thailand business. Net income attributable to owners of the parent was ¥3,143 million, down 41.0%.」

    For the first six months, revenue, operating income, ordinary income and quarterly net income attributable to owners of the parent all fell below the year-earlier levels.
  29. FY2019-Q1Lower revenue, lower operating profit, lower ordinary profit and lower net incomeAnnual report

    「As a result, revenue for the first quarter of the current consolidated fiscal period was ¥26,693 million, down 0.1% year on year, and operating income was ¥1,134 million, down 46.3%. In non-operating income and expenses, royalty income of ¥1,808 million was recorded, but equity in earnings of affiliates amounted to only ¥41 million due to weak performance in the Thailand business amid soft raw sugar prices and lower production at domestic affiliates because of weather conditions. Ordinary income was ¥3,012 million, down 32.3%, and net income attributable to owners of the parent was ¥1,929 million, down 33.9%.」

    In the first quarter, revenue declined slightly, while operating income, ordinary income and quarterly net income attributable to owners of the parent all fell below the year-earlier levels.
  30. FY2018-Q3AdvancedAnnual report

    「As a result, operating income exceeded the year-earlier level in all segments. Revenue for the first nine months of the current consolidated fiscal period was ¥80,739 million, up 2.8% year on year, and operating income was ¥5,807 million, up 39.4%. In non-operating income and expenses, an equity in loss of an affiliate was recorded, mainly because of weaker performance at an affiliate in Thailand due to depressed raw sugar prices, but ordinary income was ¥11,362 million, up 23.6%, due to royalty income of ¥5,744 million. Net income attributable to owners of the parent was ¥7,218 million, up 27.1%.」

    Operating income exceeded the year-earlier level in all segments, and revenue, operating income, ordinary income and quarterly net income attributable to owners of the parent all increased.
  31. FY2018-Q2AdvancedAnnual report

    「Operating income exceeded the year-earlier level in all segments. Revenue for the first six months of the current consolidated fiscal period was ¥52,409 million, up 2.3% year on year, and operating income was ¥3,591 million, up 60.9%. In non-operating income and expenses, ordinary income was ¥8,090 million, up 39.5%, due mainly to royalty income of ¥3,699 million and equity in earnings of affiliates of ¥791 million. Net income attributable to owners of the parent was ¥5,324 million, up 46.5%.」

    Operating income exceeded the year-earlier level in all segments, and revenue, operating income, ordinary income and quarterly net income attributable to owners of the parent all increased.
  32. FY2018-Q1AdvancedAnnual report

    「As a result, revenue for the first quarter of the current consolidated fiscal period was ¥26,709 million, up 3.3% year on year, and operating income was ¥2,111 million, up 37.6%. In non-operating income and expenses, ordinary income was ¥4,450 million, up 33.9%, due mainly to royalty income of ¥1,647 million and equity in earnings of affiliates of ¥592 million. Net income attributable to owners of the parent was ¥2,917 million, up 40.7%.」

    In the first quarter, revenue, operating profit, ordinary profit and net profit attributable to owners of the parent all exceeded the prior-year period.
  33. FY2017Higher revenue, lower operating profit, lower ordinary profit and lower net incomeAnnual report

    「As a result, revenue for the current consolidated fiscal year was ¥103,177 million, up 1.8% from the previous consolidated fiscal year, and operating income was ¥5,215 million, down 5.0%. In non-operating income and expenses, royalty income of ¥7,505 million was recorded, but equity in earnings of affiliates declined, mainly because of weaker performance at an affiliate in Thailand affected by reduced sugarcane production due to drought. Ordinary income was ¥12,494 million, down 2.4%, and net income attributable to owners of the parent was ¥7,482 million, down 1.3%.」

    For the full year, revenue increased, while operating income, ordinary income and net income attributable to owners of the parent all declined.
  34. FY2017-Q3Higher revenue, lower operating profit, lower ordinary profit and lower net incomeAnnual report

    「As a result, revenue for the first nine months of the current consolidated fiscal period was ¥78,557 million, up 2.4% year on year, and operating income was ¥4,164 million, down 13.1%. In non-operating income and expenses, royalty income of ¥5,401 million was recorded, but an equity in losses of affiliates arose, mainly because of weaker performance at an affiliate in Thailand due to drought and other factors. Ordinary income was ¥9,196 million, down 11.4%, and net income attributable to owners of the parent was ¥5,677 million, down 6.1%.」

    Revenue increased, while operating income, ordinary income and quarterly net income attributable to owners of the parent all fell below the year-earlier levels.
  35. FY2017-Q2Revenue increased and operating income declined, while net income increasedAnnual report

    「As a result, revenue for the first six months of the current consolidated fiscal period was ¥51,232 million, up 3.8% year on year, and operating income was ¥2,231 million, down 14.1%. In non-operating income and expenses, royalty income was ¥3,560 million, but equity in earnings of affiliates fell below the year-earlier level, mainly because of weaker performance at an affiliate in Thailand, resulting in ordinary income of ¥5,800 million, down 7.3%. In extraordinary income and expenses, no loss on valuation of investment securities recorded in the previous fiscal period was recognized in the current period, resulting in net income attributable to owners of the parent of ¥3,633 million, up 4.5%.」

    Revenue and net income attributable to owners of the parent increased, while operating income and ordinary income fell below the year-earlier levels, resulting in mixed performance trends.
  36. FY2017-Q1AdvancedAnnual report

    「As a result, revenue for the first quarter of the current consolidated fiscal period was ¥25,860 million, up 4.4% year on year, and operating income was ¥1,534 million, up 18.4%. In non-operating income and expenses, ordinary income was ¥3,323 million, up 7.2%, due mainly to royalty income of ¥1,630 million and equity in earnings of affiliates of ¥103 million. Net income attributable to owners of the parent was ¥2,073 million, up 8.5%.」

    Revenue, operating income, ordinary income and net income attributable to owners of the parent all exceeded the year-earlier levels in the first quarter.
  37. FY2016First statedAnnual report

    「As a result, revenue for the current consolidated fiscal year was ¥101,379 million, up 5.5% from the previous consolidated fiscal year, and operating income was ¥5,490 million, up 42.3%. In non-operating income and expenses, ordinary income was ¥12,796 million, up 34.5%, due mainly to royalty income of ¥7,406 million and equity in earnings of affiliates of ¥326 million. Net income attributable to owners of the parent was ¥7,581 million, up 32.8%.」

    The FY2016 consolidated results show actual revenue, operating income, ordinary income and net income attributable to owners of the parent, together with year-on-year changes.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Mitsui DM Sugar's next results are scheduled for 2026-10-30. Read the earnings preview It last moved in the Revision of earnings forecasts of 2026-05-15: "Other".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.